Paper7204576
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
Nussenblatt RB and 5 others. J Clin Invest, 1981. Cited by 187 papers, by iCite.
Cite this record
ConductScience Library. Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. Papers, record 7204576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7204576
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Immunosuppressive Agents | Major topic |
| Peptides, Cyclic | Major topic |
| Uveitis | Major topic |
| Animals | |
| Antibodies | |
| Antigens | |
| Arrestin | |
| Cyclosporins | |
| Female | |
| Rats |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8969 | Biological effects of cyclosporin A: a new antilymphocytic agent. | Agents Actions | 1976 | https://conductscience.org/library/papers/8969 | PubMed |
| 2 | 334977 | Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. | J Immunol | 1977 | https://conductscience.org/library/papers/334977 | PubMed |
| 3 | 91781 | Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. | Lancet | 1979 | https://conductscience.org/library/papers/91781 | PubMed |
| 4 | 6101787 | Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. | Lancet | 1980 | https://conductscience.org/library/papers/6101787 | PubMed |
| 5 | 7355973 | Cellular immune responsiveness of uveitis patients to retinal S-antigen. | Am J Ophthalmol | 1980 | https://conductscience.org/library/papers/7355973 | PubMed |
| 6 | 6445383 | Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. | J Immunol | 1980 | https://conductscience.org/library/papers/6445383 | PubMed |
| 7 | 6966620 | Experimental autoimmune uveitis: cellular immune responsiveness. | Invest Ophthalmol Vis Sci | 1980 | https://conductscience.org/library/papers/6966620 | PubMed |
| 8 | 6992646 | Enzyme-linked immunoassay (ELISA) for connective tissue components. | Anal Biochem | 1980 | https://conductscience.org/library/papers/6992646 | PubMed |
| 9 | 6992852 | Effect of cyclosporin A on the survival of corneal grafts in rabbits. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/6992852 | PubMed |
| 10 | 6447256 | Suppression of in vitro lymphocyte reactivity by cyclosporin A: existence of a population of drug-resistant cytotoxic lymphocytes. | Nature | 1980 | https://conductscience.org/library/papers/6447256 | PubMed |
| 11 | 45208 | Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. | Nature | 1979 | https://conductscience.org/library/papers/45208 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41751755 | Patterns of Inflammation in Experimental Autoimmune Uveitis and Their Correlation to Optical Coherence Tomography Findings in Human Uveitis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751755 | PubMed |
| 34733288 | Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation. | Front Immunol | 2021 | https://conductscience.org/library/papers/34733288 | PubMed |
| 32814140 | Steroid-eluting contact lenses for corneal and intraocular inflammation. | Acta Biomater | 2020 | https://conductscience.org/library/papers/32814140 | PubMed |
| 24300231 | Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems. | Pharmaceutics | 2012 | https://conductscience.org/library/papers/24300231 | PubMed |
| 24187594 | Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis. | Int J Clin Rheumtol | 2013 | https://conductscience.org/library/papers/24187594 | PubMed |
| 23626769 | Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats. | PLoS One | 2013 | https://conductscience.org/library/papers/23626769 | PubMed |
| 23617902 | Systemic therapies for inflammatory eye disease: past, present and future. | BMC Ophthalmol | 2013 | https://conductscience.org/library/papers/23617902 | PubMed |
| 21210752 | Emerging drugs for uveitis. | Expert Opin Emerg Drugs | 2011 | https://conductscience.org/library/papers/21210752 | PubMed |
| 20031223 | Cyclosporine for ocular inflammatory diseases. | Ophthalmology | 2010 | https://conductscience.org/library/papers/20031223 | PubMed |
| 18708627 | LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells. | Invest Ophthalmol Vis Sci | 2009 | https://conductscience.org/library/papers/18708627 | PubMed |
| 12539855 | Long-term therapy with low dose cyclosporin A in ocular Behçet's disease. | Doc Ophthalmol | 2002 | https://conductscience.org/library/papers/12539855 | PubMed |
| 10535846 | Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium. | Br J Ophthalmol | 1999 | https://conductscience.org/library/papers/10535846 | PubMed |
| 9497474 | Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. | Br J Ophthalmol | 1997 | https://conductscience.org/library/papers/9497474 | PubMed |
| 9135411 | Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific. | Br J Ophthalmol | 1997 | https://conductscience.org/library/papers/9135411 | PubMed |
| 8988399 | Experimental autoimmune uveitis: molecular mimicry and oral tolerance. | Immunol Res | 1996 | https://conductscience.org/library/papers/8988399 | PubMed |
| 8841518 | Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats. | Experientia | 1996 | https://conductscience.org/library/papers/8841518 | PubMed |
| 8475065 | Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8475065 | PubMed |
| 8457510 | Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. | Br J Ophthalmol | 1993 | https://conductscience.org/library/papers/8457510 | PubMed |
| 8088063 | Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy. | Clin Rheumatol | 1994 | https://conductscience.org/library/papers/8088063 | PubMed |
| 7880799 | Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis? | Br J Ophthalmol | 1995 | https://conductscience.org/library/papers/7880799 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7204576
GET https://conductscience.org/api/papers/v1/7204576/cited_by?page=2